Back to OpenRounds

Daily Briefing

Sunday, February 15, 2026

The Vibe

AI's clinical utility is getting concrete: drug safety databases are powering LLMs for hepatotoxicity predictions, while FDA approvals for blood-based Alzheimer's testing mark a shift toward accessible diagnostics [1][2]. The gap between research promises and actual implementation is narrowing, though rural hospital closures remind us that technology means nothing without accessible healthcare infrastructure [3].

Research

RAG-enhanced LLMs trained on Livertox data accurately predict drug-induced liver injury, offering a scalable approach to pharmacovigilance that could catch hepatotoxic signals earlier [1]
Deep learning models achieved strong performance classifying ovarian tumors from multicenter CT datasets, suggesting radiology AI can generalize across institutions despite imaging variations [4]
Machine learning models predict chronic pain after thoracoscopic surgery, with predictor domains spanning demographic, clinical, and procedural factors [5]
RAMA mortality risk models for NICU patients with acute kidney injury demonstrate ML's potential in high-stakes neonatal care [6]

Clinical Practice & Ops

Labcorp now offers Roche's FDA-cleared Alzheimer's blood test for primary care physicians, expanding dementia screening beyond specialized memory centers to patients 55+ with cognitive symptoms [2]
Hospital operations ended 2025 on solid financial footing with steady margins, though analysts warn of deteriorating payer mix trends and rising bad debt heading into 2026 [7]

Industry & Products

FDA cleared Encora Therapeutics' wearable wrist device for essential tremor, providing patients a non-pharmaceutical option for managing symptoms during daily activities [8]
Agilent's companion diagnostic received FDA approval alongside Keytruda's latest ovarian cancer indication, ensuring precision patient selection for immunotherapy [9]

One to Watch

Rural hospital financial distress continues accelerating with 417 facilities at closure risk — watch how this affects AI deployment strategies, since sophisticated technology requires functioning healthcare infrastructure to deliver patient benefit.